Home  >  Products  >  PTPN11 (protein tyrosine phosphatase, non-receptor type 11) Blocking Peptide (the N terminal of PTPN11)(100ug)
PTPN11 (protein tyrosine phosphatase, non-receptor type 11) Blocking Peptide (the N terminal of PTPN11)(100ug)

PTPN11 (protein tyrosine phosphatase, non-receptor type 11) Blocking Peptide (the N terminal of PTPN11)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PTPN11 Antibody(ARP56494_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP56494
Size: 100ug
Weight: 68kDa
Gene: 5781
Format: Lyophilized powder
Target: The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains two tandem Src homology-2 domains, which function as phospho-tyrosine binding domains and mediate the interaction of this PTP with its substrates. This PTP is widely expressed in most tissues and plays a regulatory role in various cell signaling events that are important for a diversity of cell functions, such as mitogenic activation, metabolic control, transcription regulation, and cell migration. Mutations in this gene are a cause of Noonan syndrome as well as acute myeloid leukemia.
Alternative names: BPTP3; CFC; MGC14433; NS1; PTP-1D; PTP2C; SH-PTP2; SH-PTP3; SHP2
See Full Product Listings >